Latest news for Procyon (OTC:PCYN) Stock

Procyon Corp is a United-based company, through its subsidiary, it is engaged in developing and marketing proprietary medical products used to treat pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems. Its wound care products are sold through distributors to institutional customers such as hospitals, wound care clinics, skilled nursing facilities, home health agencies, and physicians and other healthcare practitioners. The firm's product lines are AMERX, AMERIGEL, and HELIX3 Bioactive Collagen. The skin and wound care products are marketed under the trademark AMERIGEL which contains the proprietary ingredient OAKIN which promotes wound healing and healthy skin. The corporation markets its products in the United States.

Procyon Corp

Procyon

Fred W Suggs Jr, Director at Procyon (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PCYN#OTC">PCYN</a>), reported a large acquisition of company stock options on August 21, according to a new SEC filing.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0000812306/000143774923024334//Archives/edgar/data/812306/000143774923024334/0001437749-23-024334-index.htm">U.S. Securities and Exchange Commission</a> on Monday showed that Jr, Director at Procyon, a company in the Health Care sector, was just awarded stock options worth 25,432 shares of PCYN. The options give Jr the right to buy the company's stock at $0.25 per share.
Procyon shares are trading down 0.0% at $0.22 at the time of this writing on Tuesday morning. Since the current price is $0.22, this makes Jr's 25,432 shares worth $5,595.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Transactions Are Important</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however an insider transaction can be an important factor in the investing decision. 
In legal terms, an "insider" refers to any shareholder who owns at least 10% of a company. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Important Transaction Codes</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000812306">Check Out The Full List Of Procyon's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Procyon

News

Latest news for Procyon (OTC:PCYN) Stock

Tuesday, August 22, 2023

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga